| RoB 2: a revised tool for assessing risk of bias in randomised trials JAC Sterne, J Savović, MJ Page, RG Elbers, NS Blencowe, I Boutron, ... bmj 366, 2019 | 8277 | 2019 |
| ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions JAC Sterne, MA Hernán, BC Reeves, J Savović, ND Berkman, ... bmj 355, 2016 | 7855 | 2016 |
| Marginal structural models and causal inference in epidemiology JM Robins, MA Hernan, B Brumback Epidemiology, 550-560, 2000 | 5041 | 2000 |
| Causal inference MA Hernán, JM Robins CRC, 2010 | 2735 | 2010 |
| A structural approach to selection bias MA Hernán, S Hernández-Díaz, JM Robins Epidemiology, 615-625, 2004 | 2488 | 2004 |
| Constructing inverse probability weights for marginal structural models SR Cole, MA Hernán American journal of epidemiology 168 (6), 656-664, 2008 | 2240 | 2008 |
| BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting N Dagan, N Barda, E Kepten, O Miron, S Perchik, MA Katz, MA Hernán, ... New England Journal of Medicine, 2021 | 2136 | 2021 |
| Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts R Estruch, E Ros, J Salas-Salvadó, MI Covas, D Corella, F Arós, ... New England journal of medicine 378 (25), e34, 2018 | 2092 | 2018 |
| Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study M Pollán, B Pérez-Gómez, R Pastor-Barriuso, J Oteo, MA Hernán, ... The Lancet 396 (10250), 535-544, 2020 | 1781 | 2020 |
| Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men MÁ Hernán, B Brumback, JM Robins Epidemiology, 561-570, 2000 | 1733 | 2000 |
| Vitamin D intake and incidence of multiple sclerosis KL Munger, SM Zhang, E O’reilly, MA Hernan, MJ Olek, WC Willett, ... Neurology 62 (1), 60-65, 2004 | 1497 | 2004 |
| Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study HK Choi, MA Hernán, JD Seeger, JM Robins, F Wolfe The Lancet 359 (9313), 1173-1177, 2002 | 1475 | 2002 |
| Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology MA Hernán, S Hernández-Díaz, MM Werler, AA Mitchell American journal of epidemiology 155 (2), 176-184, 2002 | 1380 | 2002 |
| Using big data to emulate a target trial when a randomized trial is not available MA Hernán, JM Robins American journal of epidemiology 183 (8), 758-764, 2016 | 1135 | 2016 |
| Estimating causal effects from epidemiological data MA Hernán, JM Robins Journal of Epidemiology & Community Health 60 (7), 578-586, 2006 | 1013 | 2006 |
| Temporal trends in the incidence of multiple sclerosis: a systematic review A Alonso, MA Hernán Neurology 71 (2), 129-135, 2008 | 1006 | 2008 |
| Activated injectable vitamin D and hemodialysis survival: a historical cohort study M Teng, M Wolf, MN Ofsthun, JM Lazarus, MA Hernán, CA Camargo, ... Journal of the American Society of Nephrology 16 (4), 1115-1125, 2005 | 994 | 2005 |
| A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease MA Hernán, B Takkouche, F Caamaño‐Isorna, JJ Gestal‐Otero Annals of neurology 52 (3), 276-284, 2002 | 991 | 2002 |
| Instruments for causal inference: an epidemiologist's dream? MA Hernán, JM Robins Epidemiology, 360-372, 2006 | 977 | 2006 |
| The hazards of hazard ratios MA Hernán Epidemiology (Cambridge, Mass.) 21 (1), 13, 2010 | 885 | 2010 |
James M. Robinsprofessor of epidemiology and biostatistics harvard school of public healthVerified email at hsph.harvard.edu
